Exatype supports the automated analysis of data generated from Roche’s KAPA HyperCap SARS-CoV-2 panel

/images/roche/icon-hex-red.svg Hyrax Biosciences and Roche have partnered to enable integrated sample prep to reporting workflows for sequencing-based testing and research.

Pairing Hyrax Biosciences' Exatype platform with Roche's KAPA HyperCap workflow provides an integrated, end-to-end solution from sample prep through to data analysis, interpretation and reporting.

Exatype supports the automated analysis of data generated from Roche’s KAPA HyperCap SARS-CoV-2 Panel (RUO) thereby making sequencing for SARS-CoV-2 genomic surveillance faster, cheaper and more accurate.

/images/roche/top-sidebar1.svg

Viral RNA in host RNA background

/images/roche/arrow-blue.svg
/images/roche/top-sidebar2.svg

Library Prep with KAPA RNA HyperPrep Kit

/images/roche/arrow-blue.svg
/images/roche/top-sidebar3.svg

Target Enrichment with KAPA HyperCap SARS-CoV-2 panel

/images/roche/arrow-blue.svg
/images/roche/top-sidebar4.svg

Final library enriched with viral targets

/images/roche/arrow-blue.svg
/images/roche/top-sidebar5.svg

Next Gen Sequencing

/images/roche/arrow-red.svg
/images/roche/top-sidebar6.svg

Analysis and reporting using the Exatype platform

/images/roche/icon-link.svg

Try out Exatype

Sign up at hpr.exatype.com and run your first 20 samples for free!

Experience the full workflow - a demo dataset is included in the welcome email upon signup, but you are welcome to use your own Roche KAPA HyperCap SARS-CoV-2 data instead.

/images/roche/sars-cov-2-ui-create-job.png
/images/roche/sars-cov-2-ui-results.png
/images/roche/icon-diamong.svg

Benefits

Exatype has been tailored for the analysis of sequence data generated using Roche’s KAPA HyperCap SARS-CoV-2 panel:

check

Automated primer deduplication

Report variant prevalences with confidence

check

Customisable prevalence setting for variant detection

Harness the power of Exatype's algorithms in detecting low abundance variants e.g. surveillance studies and detection of dual-infection

check

Easy to use

Intuitive drag-and-drop interface means minimal end-user input needed to analyse data

check

Scalability

Scale up with ease using Hyrax Biosciences’ streamlined and secure, cloud-based IT infrastructure

check

High quality results

Confidently detect and report variants with the Exatype platform

check

Minimise time

Report your findings faster by on-cloud parallel processing using the intuitive interface of the Exatype platform

check

Proven expertise

Hyrax Biosciences’ proven expertise in viral sequence and reporting offers reliable SARS-CoV-2 surveillance

check

High-throughput

APIs enable direct integration with sequencers and/or LIMS (contact us for more information)

/images/roche/icon-magnify.svg

Further information

Brochure

Read more about the Hyrax-Roche co-promotion partnership.

download Download PDF

Presentation

Learn more about streamlining your SARS-CoV-2 sequencing with the Roche’s KAPA HyperCap SARS-CoV-2 Panel (RUO) and the Exatype platform.

download Download PDF
/images/roche/testtube-red.svg

The Exatype Platform

The capabilities of Exatype extend far beyond SARS-CoV-2; the modular platform can analyse and interpret sequence data from an ever-expanding range of applications including:

/images/roche/btm-icon1.svg

Genotyping and drug-resistance testing in infectious diseases e.g. HIV, TB, SARS-CoV-2.

/images/roche/btm-icon2.svg

Multi-target diagnostics, e.g. infectious disease panels.

/images/roche/btm-icon3.svg

Tumour profiling and drug-susceptibility testing in cancer.

/images/roche/btm-icon4.svg

Low abundance variant detection e.g. detecting mixed infections or the detection of biomarkers in liquid biopsies.

Your Sequence data.

One Solution.

Get in touch Email sending